The fake drug racketeers are spreading their tentacles fast in the rural and semi urban areas of the state. The report of the Public Analyst Laboratory (PAL), Lucknow states that majority of the samples that were found spurious and adulterated came from the ‘kasbas’ (small towns).
The Food and Drug Administration (FDA) has launched a statewide drive against fake drug and adulterated edible items. The drug inspectors picked up samples from various drug stores and dispatched it to PAL for laboratory test. During test one out of the four samples was found spurious.
The officials of FDA said to check the fake drug racket the they amended their strategy from picking samples from the retailers, wholesalers and manufacturing units on routine basis to conducting raids at the drug units on specific intelligence input.
A meeting of the officials of FDA was held under the chairmanship of Chief Minister, Mayawati last week to review the drive against fake drug. Expressing concern over fake drug the Chief Minister directed the officers to launch an awareness campaign against fake/spurious drug. Those involved in the racket should be taken into custody and given stringent punishment.
A senior officer at FDA, AL Arya said the drug inspectors conducted raids at drug outlets under the special drive launched by the department in 38 districts and 207 samples were collected. On the basis of the report of the PAL, the FDA cancelled the licence of 25 pharmaceutical companies the licence of another 44 companies was suspended. Warning had been issued to 65 companies and drug wholesalers.
The drive is focused on spurious, adulterated and misbranded drug being sold over the counter. The spurious drug is an imitation or is a substitute for another drug. The drug resembles another drug in a manner to deceive the consumer. The adulterated drug contains decomposed elements and is prepared under in sanitary condition. Large number of drug with false label termed as misbranded one are sold in the market.
The supply of spurious/ adulterated drug to the government hospitals has also come to light. Each year the Central Medicine Store Department (CMSD) floats tender for supply of the drug to the government hospitals located in 71 districts. The company which bid is lowest gets the order to supply the drug under the rate contract fixed by the Health Department. Usually the pharmaceutical companies supply sub standard quality drug. The Heath Department has decided to amend the purchase policy to open the door for the reputed companies, but in vain,
The Director CMSD, Dr Ramji Lal said the Health Department has directed the Additional Director, Health posted at divisional headquarters to purchase drug from the companies under the rate contract.
The special secretary, FDA Captain SK Dewedi said the drug inspectors have been directed that along with picking up the samples they should check the documents and stock registers of the retailers and wholesalers. In the manufacturing units they have to ascertain if the drug was manufactured under norms of the good manufacturing practice (GMP).